Graduate Diploma in Clinical Pharmacy
2008 | 2009 | 2010Division of Health Sciences | School of Pharmacy and Medical Sciences
| Program Code: IGCL Program Level: Postgraduate SATAC code: 4GD037 Home Campus:
City East Program Length (in EFTSL):
1 |
Program director/s
- Mr Stefan Kowalski (IGCL)
All applicants should note that this program is only available by external delivery. External delivery for this program is based on written and online teaching materials supplemented by three all day workshops utilising case examples twice per course. International applicants should note that this program is available only by external study in their home country with the compulsory workshops located in Adelaide or Singapore (dependent upon numbers).
HOW TO APPLY
DOMESTIC STUDENTS ONLY
Applications to this program are online via SATAC's Gradstart portal.
INTERNATIONAL STUDENTS ONLY
Applications to this program are via UniSA's Apply Online portal. Applicants should note that this program is available only by external study in their home country with the compulsory workshops located in Adelaide or Singapore (dependent upon numbers).
Aim
The Graduate Diploma in Clinical Pharmacy aims to provide practicing pharmacists with specialised training and clinical skills in selected areas of clinical practice. The program will further develop previously acquired knowledge and skills, and extend professional practice.
Entry requirements
Australian applicants are required to:
- be a Registered Pharmacist in a State or Territory of Australia
International applicants (see Note 2) are required to:
- hold an award from a tertiary institution which is at least equivalent to a Bachelor of Pharmacy (see Note 1) degree; and
- be a Registered Pharmacist in their own country or country of residence; and
- have experience in a direct patient care environment.
Note 1: to be considered equivalent to a Bachelor of Pharmacy degree, the award must have a principal focus on pharmacokinetics, applied pharmacology, disease pathophysiology and treatment. An award with a principal focus on pharmaceutical manufacturing will not be considered equivalent for entry to the program.
Note 2: International applicants who wish to study this program are advised that this program is only available externally/on-line in the student's home country. International applicants wishing to study this program externally/on-line in their home country, must meet all entry requirements, including the English Language Requirements, and must provide proof of experience in a patient care environment.
In addition, international applicants who speak English as a foreign language must have obtained one of the following standards within the last two years prior to admission:
- English Language Test (see Note 3 below)
- IELTS (International English Language Testing System
- Reading and writing- 7.0
- Overall band score- 7.0
- TOEFL (Test of English as a Foreign Language) equivalent
- IELTS (International English Language Testing System
- Other qualifications
- Successful completion of a tertiary qualification at bachelor level or above completed in Australia within the last two years; or
- Successful completion of at least two years of tertiary study at bachelor level or above conducted and completed in English within the last five years in a country in which English is commonly used, as determined by the University (see Note 4 below). Where the study in English was more than five years ago, this requirement may be satisfied by subsequent and recent work experience of at least two years duration in a setting where English is the language of business subject to satisfactory evidence as determined by the University.
Note 3: Results from IELTS and TOEFL are valid for two years
Note 4: The University, through UniSA International, maintains a list of countries where English is commonly used and which would satisfy this criterion. This may include particular educational institutions within a given non-English speaking country where English is the language of instruction.
Content/structure
The program requires completion of 36 units of study comprising introduction to the skills for clinical pharmacy practice followed by intensive pharmacotherapeutics/medication management instruction.
Fee information
Fees for Domestic students: Commonwealth SupportedFees for Commonwealth Supported Students are calculated at the course level. Click on individual courses in the schedule below to determine total program fees.
Program requirements
| Course name | Area + Cat. No. | Units | EFTSL |
|---|---|---|---|
| FIRST YEAR | |||
| First Half (Study Period 1, 2 or 3) | |||
| PHAR 5042 | 4.5 | 0.125 | |
| PHAR 5051 | 4.5 | 0.125 | |
| PHAR 5043 | 4.5 | 0.125 | |
| PHAR 5044 | 4.5 | 0.125 | |
| Second Half (Study Period 4, 5 or 6) | |||
| PHAR 5045 | 9 | 0.250 | |
| PHAR 5046 | 9 | 0.250 |
Credit transfer
Credit for the Graduate Certificate in Pharmacy Practice
Graduates of the University of South Australia's Graduate Certificate in Pharmacy Practice wishing to upgrade to the Graduate Diploma in Clinical Pharmacy award will be granted full unit credit for courses completed in the Graduate Certificate award.
Rules
- Credit for previous studies or exemption from work within courses may be granted in accordance with University policy. Maximum credit allowed is normally one third of the total units of the program.
- Students are required to satisfy the standards of dress and behaviour prescribed by institutions in which any professional placements are undertaken. Failure to satisfy such requirements may prevent a student from completing the program.
Notes
- To be considered equivalent, the Bachelor of Pharmacy degree must have a principal focus on pharmacokinetics, applied pharmacology, disease pathophysiology and treatment. A Bachelor of Pharmacy degree with a principal focus on pharmaceutical manufacturing will not be considered equivalent for entry into the program.
- The program aims to produce clinical pharmacists capable of providing specialist pharmaceutical services in hospitals and other clinical environments, thereby enhancing the quality use of medicines. The program builds on skills of practice developed as an undergraduate student and is therefore not a pathway to registration as a pharmacist in Australia.
